Genomic variants-driven drug repurposing for tuberculosis by utilizing the established bioinformatic-based approach

A major challenge in translating genomic variants of Tuberculosis (TB) into clinical implementation is to integrate the disease-associated variants and facilitate drug discovery through the concept of genomic-driven drug repurposing. Here, we utilized two established genomic databases, namely a Geno...

Descripción completa

Detalles Bibliográficos
Autores principales: Irham, Lalu Muhammad, Adikusuma, Wirawan, Perwitasari, Dyah Aryani
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9449755/
https://www.ncbi.nlm.nih.gov/pubmed/36090591
http://dx.doi.org/10.1016/j.bbrep.2022.101334

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9449755/
https://www.ncbi.nlm.nih.gov/pubmed/36090591
http://dx.doi.org/10.1016/j.bbrep.2022.101334

Ejemplares similares